Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Br J Cancer. 2012 Sep 4;107(6):956-60. doi: 10.1038/bjc.2012.353. Epub 2012 Aug 14.
Br J Cancer. 2012.
PMID: 22892393
Free PMC article.
Clinical Trial.
Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.
Issa-Nummer Y, Darb-Esfahani S, Loibl S, Kunz G, Nekljudova V, Schrader I, Sinn BV, Ulmer HU, Kronenwett R, Just M, Kühn T, Diebold K, Untch M, Holms F, Blohmer JU, Habeck JO, Dietel M, Overkamp F, Krabisch P, von Minckwitz G, Denkert C.
Issa-Nummer Y, et al.
PLoS One. 2013 Dec 2;8(12):e79775. doi: 10.1371/journal.pone.0079775. eCollection 2013.
PLoS One. 2013.
PMID: 24312450
Free PMC article.
Clinical Trial.
Item in Clipboard
Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy.
Issa-Nummer Y, Loibl S, von Minckwitz G, Denkert C.
Issa-Nummer Y, et al.
Oncoimmunology. 2014 Feb 14;3:e27926. doi: 10.4161/onci.27926. eCollection 2014.
Oncoimmunology. 2014.
PMID: 25340002
Free PMC article.
Item in Clipboard
Cite
Cite